OrganTech Grants Domestic Manufacturing License for Cell-Derived Components, Including the 'Third Cell'
NQ Score
89/100
N1 Content Completeness
95
AI Summary (NQ-processed)
OrganTech has granted a manufacturing license for its proprietary 'third cell' (hair follicle regeneration-supporting cell) and related cell-derived components to Kojin Bio. The partnership aims to accelerate hair regenerative medicine and related product development.
AI Analysis
Frequently Asked Questions
- Q: What kind of company is OrganTech?
- A: OrganTech is a biotech startup dedicated to research and development of innovative regenerative medicine for hair and skin.
- Q: Why did they partner with Kojin Bio?
- A: To accelerate commercialization by combining Kojin Bio's cell culture expertise with OrganTech's proprietary regenerative cells.
- Q: What is the future outlook?
- A: The company aims to accelerate hair regenerative medicine and research products derived from these cells in partnership with various companies.